Summary: Robb Report explores the ways psychedelics are becoming a more widely known and plausible treatment for medical conditions like PTSD, addiction, depression, and more. Author Alyson Krueger highlights MAPS-sponsored psychedelic research and how “We are now in the third wave, characterized by serious studies elevating psychedelics to the level of medicines” because of “non-profit players in the field.”
Rachel Yehuda, Ph.D., Director of the Center for Psychedelic Psychotherapy and Trauma Research at the Icahn School of Medicine at Mount Sinai, notes that, “When studies showed promising results, other scientists were forced to pay attention. A lot of people have paved the way for us to not be scared of psychedelics and understand that in the right environment and in the right container, they can be very useful.”
Robb Report: Good Trip? How Psychiatrists Got Serious About Using Psychedelics to Treat Mental Health
